290 related articles for article (PubMed ID: 28627939)
1. Off-label prescribing for children with chronic diseases in Nigeria; findings and implications.
Oshikoya KA; Oreagba IA; Godman B; Fadare J; Orubu S; Massele A; Senbanjo IO
Expert Opin Drug Saf; 2017 Sep; 16(9):981-988. PubMed ID: 28627939
[TBL] [Abstract][Full Text] [Related]
2. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
3. Off-label paediatric drug use in an Indonesian community setting.
Abdulah R; Khairinisa MA; Pratiwi AA; Barliana MI; Pradipta IS; Halimah E; Diantini A; Lestari K
J Clin Pharm Ther; 2015 Aug; 40(4):409-12. PubMed ID: 25884353
[TBL] [Abstract][Full Text] [Related]
4. Changes in anticonvulsant prescribing for Australian children: implications for Quality Use of Medicines.
Cohen SA; Lawson JA; Graudins LV; Pearson SA; Gazarian M
J Paediatr Child Health; 2012 Jun; 48(6):490-5. PubMed ID: 22050665
[TBL] [Abstract][Full Text] [Related]
5. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
[TBL] [Abstract][Full Text] [Related]
6. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
7. Respiratory drugs prescribed off-label among children in the outpatient clinics of a hospital in Malaysia.
Mohamad NF; Mhd Ali A; Mohamed Shah N
Int J Clin Pharm; 2015 Feb; 37(1):127-32. PubMed ID: 25488318
[TBL] [Abstract][Full Text] [Related]
8. Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches.
Carnovale C; Conti V; Perrone V; Antoniazzi S; Pozzi M; Merlino L; Venegoni M; Clementi E; Radice S
Eur J Pediatr; 2013 Dec; 172(12):1679-85. PubMed ID: 23913312
[TBL] [Abstract][Full Text] [Related]
9. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
[No Abstract] [Full Text] [Related]
10. Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care--a nationwide study.
Olsson J; Kimland E; Pettersson S; Odlind V
Acta Paediatr; 2011 Sep; 100(9):1272-5. PubMed ID: 21438922
[TBL] [Abstract][Full Text] [Related]
11. Off-label prescribing to children in the United States outpatient setting.
Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
[TBL] [Abstract][Full Text] [Related]
12. Prescription Pattern Monitoring and Off-label Use of Medicines in the Pediatric Department at Tertiary Care Teaching Hospital.
Pandey S; Yadav CK; Ghimire P; Shrestha AC
Kathmandu Univ Med J (KUMJ); 2020 Oct.-Dec.; 18(72):367-371. PubMed ID: 34165093
[TBL] [Abstract][Full Text] [Related]
13. Off-label drug use among hospitalised children: identifying areas with the highest need for research.
Hsien L; Breddemann A; Frobel AK; Heusch A; Schmidt KG; Läer S
Pharm World Sci; 2008 Oct; 30(5):497-502. PubMed ID: 18219585
[TBL] [Abstract][Full Text] [Related]
14. Paediatric off-label and unlicensed prescribing in primary care in Malta: Prospective observational drug utilisation study.
Ellul IC; Grech V; Attard-Montalto S
Int J Risk Saf Med; 2015; 27(3):123-34. PubMed ID: 26410246
[TBL] [Abstract][Full Text] [Related]
15. Drug utilization and off-label drug use among Spanish emergency room paediatric patients.
Morales-Carpi C; Estañ L; Rubio E; Lurbe E; Morales-Olivas FJ
Eur J Clin Pharmacol; 2010 Mar; 66(3):315-20. PubMed ID: 19936729
[TBL] [Abstract][Full Text] [Related]
16. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
17. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
Borges AP; Campos MS; Pereira LR
Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
[TBL] [Abstract][Full Text] [Related]
19. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.
Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O
Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):413-420. PubMed ID: 27623818
[TBL] [Abstract][Full Text] [Related]
20. Off-label prescribing to children in primary care: retrospective observational study.
Ekins-Daukes S; Helms PJ; Simpson CR; Taylor MW; McLay JS
Eur J Clin Pharmacol; 2004 Jul; 60(5):349-53. PubMed ID: 15146302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]